Year after year, our “Conversation with Experts Luncheon" is a favorite special event at the World Stem Cell Summit. This Monday, December 3rd, grab a gourmet boxed lunch and select from dozens of intimate table discussions led by experts you have always wanted to meet.
The “Conversation with Experts Luncheon" is an opportunity for all Summit attendees to join informal roundtable discussions focusing on all aspects of stem cells and regenerative medicine, including science, business, public policy, ethics, education, advocacy and commercialization strategies. This luncheon is a unique opportunity to build your strategic relationships and have your questions answered.
More topics are added daily. This year's "Conversation with Experts Luncheon" topics include:
MSCs: The New All-Purpose Medicine
Arnold Caplan, PhD, Professor of Biology, Director Skeletal Research Center, Case Western Reserve University
The First Macular Degeneration Clinical Trial Using Human Embryonic Stem Cells
Matthew Vincent, PhD, Director Business Development, Advanced Cell Technology, Inc.
Regenerative Medicine for Aging: the Molecular Dimension
Aubrey de Grey, PhD, Chief Science Officer, SENS Foundation
Engineered Mesenchymal Stem Cells (MSC's) for Immunomodulation
Graca Almeida-Porada, MD, PhD, Professor, Wake Forest Institute for Regenerative Medicine
PSC-based Therapy for Parkinson's Disease:* The Path to an IND
Xianmin Zeng, PhD, Associate Professor and Director CIRM Shared Research Laboratory for Stem Cell & Aging, Buck Institute for Research and Aging
Development of Immunotherapy from Human Pluripotent Stem Cells
Dan S. Kaufman, MD, PhD, Associate Professor, Department of Medicine Division of Hematology, Oncology and Transplantation Associate Director, Stem Cell Institute, University of Minnesota
We have lift-off!- Launching Your Stem Cell Start-up Company
James F. Eliason, PhD, Executive Director, Great Lakes Stem Cell Innovation Center
What Would You Say? Stem Cell Advocacy and the Elevator speech: Talking Points that Work from "Uncle Fox" to Capitol Hill
Mary Schneider, Legislative Advocate, Children's Neurobiological Solutions (CNS) Foundation
You Won't Get Anywhere Without Figuring Out the Intellectual Property
Nicholas Zachariades, PhD, Duane Morris, LLP
The Department of Defense and the Vatican as a Source of Non-Dilutive Funding to Advance Stem Cell Science
Robin Smith, MD, MBA, Chief Executive Officer & Chairman of the Board of Directors, NeoStem, Inc.
Process Development Challenges for Cell Therapy Manufacturing Success
Robert Shaw, Commercial Director - Stem Cell Initiative, EMD Millipore Corp.
Establishing Effective Strategic Partnerships Between Pharma and Cell Therapy Startups
Scott Burger, MD, Advanced Cell & Gene Therapy, LLC
Funding and Commercialization Issue for RM Technologies
Gregory A. Bonfiglio, Proteus Venture Partners
The ALS Clinic Experience: The Good, The Bad and the Ugly
Stephen Byer, Founder and Co-Executive Director, ALS Worldwide
Collaboration Opportunities with the California Institute for Regenerative Medicine (CIRM)
Elona Baum, General Counsel and Vice-President, California Institute for Regenerative Medicine (CIRM)
The Transformative Impact of Insurance Reimbursements for Cell Therapies
Dr. Cathy Prescott, Biolatris Ltd, Cambridge, UK
How iPS cells Changed the Stem Cell Research Universe
Paul Knoepfler, PhD, Associate Professor, UC Davis Institute for Regenerative Cures
Educating the Public about Stem Cell Research
Don L. Gibbons, Senior Science and Education Communications Officer, California Institute for Regenerative Medicine (CIRM)
The State of Affairs for Human Embryology Research and Clinical Translation
Alan Jakimo, Sidley Austin, LLP
Alliance for Regenerative Medicine (ARM)- Washington Round-Up
Michael Werner, Holland & Knight, LLP
Exciting Discoveries at Hadassah in Israel.
Prof. Raphael Gorodetsky, Ph.D., Head of Biotechnology and Radiobiology Laboratory, Sharett Institute of Oncology, Hadassah - Hebrew University Medical Center
Schwann Cells Versus Stem Cells for Spinal Cord Injury
James Guest MD, PhD, FACS, Associate Professor of Neurological Surgery, Miami Project to Cure Paralysis
Cord Blood Banking- Global Industry
Amnon Pelz, Taburit, Israel
Adoptive Cell Therapy of Cancer
Avi Treves, PhD, Cancer Research Center, Sheba Medical Center
How can Academia, Foundations and Biopharma Work Together?
Brock Reeve, Executive Director, Harvard Stem Cell Institute
Bioethical Considerations of Embryonic Stem Cell Research and Alternatives
Robin Fiore, PhD, University of Miami Ethics Programs, University of Miami Miller School of Medicine
What Investors Should Look for in the Regenerative Medicine Space
Robin Young, CEO and Founder, AFCell Medical and Orthopedics This Week
Strategies to Alleviate Chronic Pain and Reverse Paralysis
Mark Noble, PhD, Director, UR Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center
Protecting Freedom of Scientific Inquiry - State Battlegrounds
Victoria Kohout, Nebraska Coalition for Lifesaving Cures
Using Stem Cells to Find a Cure for Diabetes
Juan Dominguez-Bendala, Msc, PhD, Director, Pancreatic Development & Stem Cell Laborator, Diabetes Research Institute
Stem Cells 101- All Your Questions Answered
Marion "Joe" Riggs, Founder and Executive Director, Student Society for Stem Cell Research
A Patient's Perspective on Participating in a Stem Cell Clinical Trial
Barry Brown, Clinical Trial Participant
What's Wrong (or Right) with Texas and Stem Cells?
Keri Kimler, Founder, Texas Cures Education Foundation
The “Conversation with Experts Luncheon" is an opportunity for all Summit attendees to join informal roundtable discussions focusing on all aspects of stem cells and regenerative medicine, including science, business, public policy, ethics, education, advocacy and commercialization strategies. This luncheon is a unique opportunity to build your strategic relationships and have your questions answered.
More topics are added daily. This year's "Conversation with Experts Luncheon" topics include:
MSCs: The New All-Purpose Medicine
Arnold Caplan, PhD, Professor of Biology, Director Skeletal Research Center, Case Western Reserve University
The First Macular Degeneration Clinical Trial Using Human Embryonic Stem Cells
Matthew Vincent, PhD, Director Business Development, Advanced Cell Technology, Inc.
Regenerative Medicine for Aging: the Molecular Dimension
Aubrey de Grey, PhD, Chief Science Officer, SENS Foundation
Engineered Mesenchymal Stem Cells (MSC's) for Immunomodulation
Graca Almeida-Porada, MD, PhD, Professor, Wake Forest Institute for Regenerative Medicine
PSC-based Therapy for Parkinson's Disease:* The Path to an IND
Xianmin Zeng, PhD, Associate Professor and Director CIRM Shared Research Laboratory for Stem Cell & Aging, Buck Institute for Research and Aging
Development of Immunotherapy from Human Pluripotent Stem Cells
Dan S. Kaufman, MD, PhD, Associate Professor, Department of Medicine Division of Hematology, Oncology and Transplantation Associate Director, Stem Cell Institute, University of Minnesota
We have lift-off!- Launching Your Stem Cell Start-up Company
James F. Eliason, PhD, Executive Director, Great Lakes Stem Cell Innovation Center
What Would You Say? Stem Cell Advocacy and the Elevator speech: Talking Points that Work from "Uncle Fox" to Capitol Hill
Mary Schneider, Legislative Advocate, Children's Neurobiological Solutions (CNS) Foundation
You Won't Get Anywhere Without Figuring Out the Intellectual Property
Nicholas Zachariades, PhD, Duane Morris, LLP
The Department of Defense and the Vatican as a Source of Non-Dilutive Funding to Advance Stem Cell Science
Robin Smith, MD, MBA, Chief Executive Officer & Chairman of the Board of Directors, NeoStem, Inc.
Process Development Challenges for Cell Therapy Manufacturing Success
Robert Shaw, Commercial Director - Stem Cell Initiative, EMD Millipore Corp.
Establishing Effective Strategic Partnerships Between Pharma and Cell Therapy Startups
Scott Burger, MD, Advanced Cell & Gene Therapy, LLC
Funding and Commercialization Issue for RM Technologies
Gregory A. Bonfiglio, Proteus Venture Partners
The ALS Clinic Experience: The Good, The Bad and the Ugly
Stephen Byer, Founder and Co-Executive Director, ALS Worldwide
Collaboration Opportunities with the California Institute for Regenerative Medicine (CIRM)
Elona Baum, General Counsel and Vice-President, California Institute for Regenerative Medicine (CIRM)
The Transformative Impact of Insurance Reimbursements for Cell Therapies
Dr. Cathy Prescott, Biolatris Ltd, Cambridge, UK
How iPS cells Changed the Stem Cell Research Universe
Paul Knoepfler, PhD, Associate Professor, UC Davis Institute for Regenerative Cures
Educating the Public about Stem Cell Research
Don L. Gibbons, Senior Science and Education Communications Officer, California Institute for Regenerative Medicine (CIRM)
The State of Affairs for Human Embryology Research and Clinical Translation
Alan Jakimo, Sidley Austin, LLP
Alliance for Regenerative Medicine (ARM)- Washington Round-Up
Michael Werner, Holland & Knight, LLP
Exciting Discoveries at Hadassah in Israel.
Prof. Raphael Gorodetsky, Ph.D., Head of Biotechnology and Radiobiology Laboratory, Sharett Institute of Oncology, Hadassah - Hebrew University Medical Center
Schwann Cells Versus Stem Cells for Spinal Cord Injury
James Guest MD, PhD, FACS, Associate Professor of Neurological Surgery, Miami Project to Cure Paralysis
Cord Blood Banking- Global Industry
Amnon Pelz, Taburit, Israel
Adoptive Cell Therapy of Cancer
Avi Treves, PhD, Cancer Research Center, Sheba Medical Center
How can Academia, Foundations and Biopharma Work Together?
Brock Reeve, Executive Director, Harvard Stem Cell Institute
Bioethical Considerations of Embryonic Stem Cell Research and Alternatives
Robin Fiore, PhD, University of Miami Ethics Programs, University of Miami Miller School of Medicine
What Investors Should Look for in the Regenerative Medicine Space
Robin Young, CEO and Founder, AFCell Medical and Orthopedics This Week
Strategies to Alleviate Chronic Pain and Reverse Paralysis
Mark Noble, PhD, Director, UR Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center
Protecting Freedom of Scientific Inquiry - State Battlegrounds
Victoria Kohout, Nebraska Coalition for Lifesaving Cures
Using Stem Cells to Find a Cure for Diabetes
Juan Dominguez-Bendala, Msc, PhD, Director, Pancreatic Development & Stem Cell Laborator, Diabetes Research Institute
Stem Cells 101- All Your Questions Answered
Marion "Joe" Riggs, Founder and Executive Director, Student Society for Stem Cell Research
A Patient's Perspective on Participating in a Stem Cell Clinical Trial
Barry Brown, Clinical Trial Participant
What's Wrong (or Right) with Texas and Stem Cells?
Keri Kimler, Founder, Texas Cures Education Foundation